BREAST CANCER BASE

Research found that the use of estrogen and progesterone hormone replacement therapy for a breast cancer can increase the incidence of breast cancer twice.

Fred Hutchinson Cancer Research Center in Seattle, scientists above the age of 50 at least 537 patients with breast cancer were studied, their sick time in 1988-1990. Then they did not have the same 492 female breast cancer were compared. Scientists found that combination therapy for at least 6 months (average 4 years) with the incidence of lobular breast cancer is another group of patients was 2.6 times more.

Nowadays, many breast enhancement products "becomes a blur", "curve enticing to you" advertisements to attract the majority of women. However, clinical observations indicated that the abuse of hormone Bust products, may raise breast cancer morbidity.

It is understood that the incidence of breast cancer and breast tissue exposed to estrogen's time-related. Now medical science has confirmed that the female hormone secretion in vivo once imbalances, in particular excessive secretion of estrogen, breast ductal epithelial cells of the estrogen stimulated by the normal development of dysplasia, to turn cancerous.

Endocrine drugs with easy-to-use, fast in extensive clinical applications, and to replace the endocrine glands (ovary, adrenal and pituitary) castration trend. Currently more clinical breast cancer patients according to the menses (that is, whether menopause) to choose a different type of endocrine treatment. The goal of treatment, amenorrhea against ovarian ago, after amenorrhea to cut off the sources of estrogen or estrogen inhibition of the main activities. As selection criteria, endocrine drugs can improve the efficacy of treatment.
Endocrine drugs treatment by the end of the cancer or estrogen antagonist, inhibited the effect of estrogen, tumor regression. Furthermore, it will eliminate micro metastasis, and improve the living quality and disease-free survival.

Mastalgias In recent years, the incidence rate is gradually increased, according to the analysis of experts, may be linked to the following factors :

(1) of the breast is a sex hormone target organs, endocrine environment by the impact of cyclical changes. When the "sexual" environment and the stimulation to expand the opportunities, and increases could make the "emotion -" secretion, resulting in the increase of estrogen and progesterone decrease relative mastalgias occurred.

(2) Some women, especially the elderly, to skin care, long-term use of estrogen-containing cream, so intimate estrogen levels were relatively high, it can be induced long the disease.